Clinical Trial Update: Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure [Phase 3]

View source ↗

Summary

A Phase 3 non-inferiority trial comparing Actparin to heparin sodium in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Actparin
• HEPARIN SODIUM (HEPARIN SODIUM)

Snippet

Sponsor: Laboratório Químico Farmacêutico Bergamo Ltda. | Conditions: Chronic Renal Failure | Phase 3 | Status: UNKNOWN